Wu et al. 2024 (PRJNA955270)
General Details
Title | Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming (Ribosome profiling) |
---|---|
Organism | |
Number of Samples | 6 |
Release Date | 2023/04/13 00:00 |
Sequencing Types | |
Protocol Details |
Study Links
GWIPS-viz | Trips-Viz |
---|---|
Repository Details
SRA | SRP432587 |
---|---|
ENA | SRP432587 |
GEO | GSE229672 |
BioProject | PRJNA955270 |
Publication
Title | |
---|---|
Authors | Wu X, Yuan H, Wu Q, Gao Y, Duan T, Yang K, Huang T, Wang S, Yuan F, Lee D, Taori S, Plute T, Heissel S, Alwaseem H, Isay-Del Viscio M, Molina H, Agnihotri S, Hsu DJ, Zhang N, Rich JN |
Journal | Nature cancer |
Publication Date | 2024 Jul |
Abstract | Cancers commonly reprogram translation and metabolism, but little is known about how these two features coordinate in cancer stem cells. Here we show that glioblastoma stem cells (GSCs) display elevated protein translation. To dissect underlying mechanisms, we performed a CRISPR screen and identified YRDC as the top essential transfer RNA (tRNA) modification enzyme in GSCs. YRDC catalyzes the formation of N 6 -threonylcarbamoyladenosine (t 6 A) on ANN-decoding tRNA species (A denotes adenosine, and N denotes any nucleotide). Targeting YRDC reduced t 6 A formation, suppressed global translation and inhibited tumor growth both in vitro and in vivo. Threonine is an essential substrate of YRDC. Threonine accumulated in GSCs, which facilitated t 6 A formation through YRDC and shifted the proteome to support mitosis-related genes with ANN codon bias. Dietary threonine restriction (TR) reduced tumor t 6 A formation, slowed xenograft growth and augmented anti-tumor efficacy of chemotherapy and anti-mitotic therapy, providing a molecular basis for a dietary intervention in cancer treatment. © 2024. The Author(s), under exclusive licence to Springer Nature America, Inc. |
PMC | PMC11552442 |
PMID | 38519786 |
DOI |
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRR24164287 | PRJNA955270 | Homo sapiens | GSC456NA_glioblastoma stem cell | 0.0 | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR24164286 | PRJNA955270 | Homo sapiens | GSC456NA_glioblastoma stem cell | 0.0 | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR24164284 | PRJNA955270 | Homo sapiens | GSC456NA_glioblastoma stem cell | 0.0 | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR24164283 | PRJNA955270 | Homo sapiens | GSC456NA_glioblastoma stem cell | 0.0 | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR24164285 | PRJNA955270 | Homo sapiens | GSC456NA_glioblastoma stem cell | 0.0 | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR24164282 | PRJNA955270 | Homo sapiens | GSC456NA_glioblastoma stem cell | 0.0 | 0.0 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) |
ⓘ For more Information on the columns shown here see: About